Gilead Sciences (GILD)

$63.98 0.14 (0.22%)

13:49 EDT GILD Stock Quote Delayed 30 Minutes

7 Dividend Stocks Paying Over 5% to Buy Now

By Chris Lau, InvestorPlace Contributor Apr 26, 2022

Stock markets will return less this year as interest rates rise and cause a recession, so investors should demand higher yield.

The 7 Highest Dividend Stocks for Income Investors

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

7 Safe Stocks for Your Retirement

Volume:

Previous Close -

Market Cap 80.22B

PE Ratio 17.87

EPS 3.58

Volume (Avg. Vol.) 3.39M

Day's Range $63.78 - $64.83

52-Week Range $57.19 - $74.12

Dividend & Yield $2.84 (4.44%)

GILD Stock Predictions, Articles, and Gilead Sciences News

From InvestorPlace
From the Web

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

5 M&A Stocks to Watch as Goldman Calls for a Big Jump in Deals

By Samuel O'Brient, InvestorPlace Financial News Writer Nov 1, 2021

Goldman Sachs predicts the Democrats' new tax plan could yield positive results for M&A-focused companies. Here are the M&A stocks to watch.

3 Value Stocks to Buy While You Still Can

By David Cohne, StockNews.com Sep 20, 2021

Value stocks have been underperforming over the past few months, but that is expected to change as the economy continues to recover.

7 Stocks to Buy for Responsibility and Sustainability

By Josh Enomoto, InvestorPlace Contributor Aug 4, 2021

With social responsibility taking a greater role in politics and Wall Street, these ESG stocks may find favor in your portfolio.

10 Best Stocks to Buy to Build Up Passive Income Streams

By Ian Bezek, InvestorPlace Contributor Jun 24, 2021

These income stocks boast huge dividend growth rates and should generate large passive income streams over the next decade.

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

By Josh Enomoto, InvestorPlace Contributor May 26, 2021

The pandemic bolstered many stocks to buy. But with cases fading, this narrative is now questionable. These seven stocks require caution.

2 Must-Own Biotech Stocks to Buy in May

By David Cohne, StockNews.com Apr 29, 2021

After a stellar rally in 2020, biotech stocks have been selling off over the past couple of months. This offers investors a buying opportunity to scoop up quality biotech stocks at cheaper prices.

Vaccitech IPO: When Does Vaccitech Go Public? What Is the VACC Stock IPO Price Range?

By Chris MacDonald, InvestorPlace Contributor Apr 28, 2021

The upcoming Vaccitech IPO is one I think investors will have their eye on, as speculators look for early stage biopharma plays today.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel Apr 28, 2021

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

7 Healthcare Stocks for a Reopening World

By Tezcan Gecgil, InvestorPlace Contributor Apr 26, 2021

The stock market is at all-time highs, and the world is starting to reopen. But these healthcare stocks have more growth opportunities ahead.

7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic

By Tezcan Gecgil, InvestorPlace Contributor Apr 1, 2021

Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

7 Value Stocks Everyone Is Ignoring

By Tezcan Gecgil, InvestorPlace Contributor Mar 24, 2021

Blue chips and companies on the rebound. Here are seven of the best value stocks for long-term investors.

7 High-Yield Stocks for Your Retirement Nest Egg

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Mar 15, 2021

High-dividend names are some of the best retirement stocks and can be a good way to achieve strong long-term growth for your portfolio.

3 Deep Value Stocks for Income and High Total Returns

By Bob Ciura, Sure Dividend Mar 11, 2021

Look to these value stocks for a great blend of dividend safety, payout growth, current yield and capital appreciation potential.

7 Pharmaceutical Stocks With Compelling Pipelines

By Chris Lau, InvestorPlace Contributor Feb 2, 2021

Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.

5 Undervalued Dividend Stocks to Buy

By Thomas Niel Dec 31, 2020

With markets at record highs and interest rates at record lows, consider these five dividend stocks to buy for value and yield.

3 Cheap Stocks Worth Buying Right Now

By Chris Tyler, InvestorPlace Contributor Dec 2, 2020

Cheap stocks can come with many caveats. But sometimes, and as these three companies shares point at, they come equipped with some real value.

Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand

By Josh Enomoto, InvestorPlace Contributor Nov 24, 2020

As Pfizer and Moderna take the lead in the novel coronavirus vaccine race, here’s how this affects other Covid-19-related biotech stocks.

4 Top Biotech Stocks to Buy for Operation Warp Speed

By Joel Baglole Nov 3, 2020

The U.S. government has pulled out all the stops to develop a treatment for Covid-19. These biotech stocks are leading the race for a cure.

Which Biotech Stocks Are a Buy on Earnings?

By Louis Navellier, Editor, Growth Investor Nov 3, 2020

If you’re interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip.

Over the past 3 months, 10 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation

From Benzinga May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Arcus Posts Encouraging Data For Domvanalimab-Based Regimes In Lung Cancer Settings

From Benzinga May 10, 2022

Why These Analysts Are Bullish On Gilead's Q1 Earnings

From Benzinga Apr 29, 2022

Gilead Sciences (GILD)

7 Dividend Stocks Paying Over 5% to Buy Now

The 7 Highest Dividend Stocks for Income Investors

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

7 Safe Stocks for Your Retirement

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gilead Sciences (GILD)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GILD Stock Predictions, Articles, and Gilead Sciences News

Subscriber Sign in